BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 26104658)

  • 21. Cerebral microbleeds and vascular cognitive impairment.
    Werring DJ; Gregoire SM; Cipolotti L
    J Neurol Sci; 2010 Dec; 299(1-2):131-5. PubMed ID: 20850134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remote Lower White Matter Integrity Increases the Risk of Long-Term Cognitive Impairment After Ischemic Stroke in Young Adults.
    Schaapsmeerders P; Tuladhar AM; Arntz RM; Franssen S; Maaijwee NA; Rutten-Jacobs LC; Schoonderwaldt HC; Dorresteijn LD; van Dijk EJ; Kessels RP; de Leeuw FE
    Stroke; 2016 Oct; 47(10):2517-25. PubMed ID: 27625378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comorbid amyloid-β pathology affects clinical and imaging features in VCD.
    Leijenaar JF; Groot C; Sudre CH; Bergeron D; Leeuwis AE; Cardoso MJ; Carrasco FP; Laforce R; Barkhof F; van der Flier WM; Scheltens P; Prins ND; Ossenkoppele R
    Alzheimers Dement; 2020 Feb; 16(2):354-364. PubMed ID: 31786129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment.
    Black S; Gao F; Bilbao J
    Stroke; 2009 Mar; 40(3 Suppl):S48-52. PubMed ID: 19064767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Leukoaraiosis. Clinical importance and prognosis].
    Valencia C; Marti-Fàbregas J; Belvis R; Martí-Vilalta JL
    Neurologia; 2003 Apr; 18(3):149-57. PubMed ID: 12677481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.
    Debette S; Markus HS
    BMJ; 2010 Jul; 341():c3666. PubMed ID: 20660506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies.
    Hu HY; Ou YN; Shen XN; Qu Y; Ma YH; Wang ZT; Dong Q; Tan L; Yu JT
    Neurosci Biobehav Rev; 2021 Jan; 120():16-27. PubMed ID: 33188821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of prestroke cognitive impairment in stroke associated with small vessel disease.
    Mok V; Wong A; Tang WK; Lam WW; Fan YH; Richards PS; Wong KT; Ahuja AT; Wong KS
    Dement Geriatr Cogn Disord; 2005; 20(4):225-30. PubMed ID: 16088138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathoconnectomics of cognitive impairment in small vessel disease: A systematic review.
    Dey AK; Stamenova V; Turner G; Black SE; Levine B
    Alzheimers Dement; 2016 Jul; 12(7):831-45. PubMed ID: 26923464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline predictors of cognitive decline in patients with cerebral small vessel disease.
    Pavlovic AM; Pekmezovic T; Tomic G; Trajkovic JZ; Sternic N
    J Alzheimers Dis; 2014; 42 Suppl 3():S37-43. PubMed ID: 24898641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic associations of leukoaraiosis indicate pathophysiological mechanisms in white matter lesions etiology.
    Lin Q; Huang WQ; Tzeng CM
    Rev Neurosci; 2015; 26(3):343-58. PubMed ID: 25781674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excessive variability in systolic blood pressure that is self-measured at home exacerbates the progression of brain white matter lesions and cognitive impairment in the oldest old.
    Liu Z; Zhao Y; Zhang H; Chai Q; Cui Y; Diao Y; Xiu J; Sun X; Jiang G
    Hypertens Res; 2016 Apr; 39(4):245-53. PubMed ID: 26631851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
    J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging.
    Bos D; Vernooij MW; Elias-Smale SE; Verhaaren BF; Vrooman HA; Hofman A; Niessen WJ; Witteman JC; van der Lugt A; Ikram MA
    Alzheimers Dement; 2012 Oct; 8(5 Suppl):S104-11. PubMed ID: 22537801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive Decline.
    Benedictus MR; van Harten AC; Leeuwis AE; Koene T; Scheltens P; Barkhof F; Prins ND; van der Flier WM
    Stroke; 2015 Sep; 46(9):2661-4. PubMed ID: 26173729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower glomerular filtration rate associated with white matter hyperintensities more in vascular dementia than in Alzheimer's disease.
    Lee KS; Na DL; Seo SW; Kim JH; Choi SH; Oh BH; Son SJ; Hong CH
    J Am Geriatr Soc; 2015 Jan; 63(1):182-3. PubMed ID: 25597572
    [No Abstract]   [Full Text] [Related]  

  • 37. The Cognition and Affect after Stroke - a Prospective Evaluation of Risks (CASPER) study: rationale and design.
    Douven E; Schievink SH; Verhey FR; van Oostenbrugge RJ; Aalten P; Staals J; Köhler S
    BMC Neurol; 2016 May; 16():65. PubMed ID: 27176617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroticism and white matter hyperintensities.
    Terracciano A; Cenatus B; Zhu X; Karakose S; Stephan Y; Marcolini S; De Deyn PP; Luchetti M; Sutin AR
    J Psychiatr Res; 2023 Sep; 165():174-179. PubMed ID: 37506413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroanatomical Correlates of Hypophonia in Subcortical Vascular Cognitive Impairment.
    Yoon JH; Ahn Y; Kim SH; Chin J; Park S; Na DL
    Eur Neurol; 2017; 78(1-2):93-104. PubMed ID: 28738366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [White matter alterations in neurodegenerative and vascular dementia].
    Supprian T; Kessler H; Retz W; Rösler M; Grunwald I; Reith W; Falkai P
    Radiologe; 2003 Jul; 43(7):543-51. PubMed ID: 12955217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.